tetano
Editor, Senior Moderator
J Intensive Care
. 2021 Jan 12;9(1):9.
doi: 10.1186/s40560-020-00519-3.
Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis
Arief Wibowo[SUP] 1 [/SUP], Raymond Pranata[SUP] 1 2 [/SUP], Astri Astuti[SUP] 1 [/SUP], Badai Bhatara Tiksnadi[SUP] 1 [/SUP], Erwan Martanto[SUP] 1 [/SUP], Januar Wibawa Martha[SUP] 1 [/SUP], Augustine Purnomowati[SUP] 1 [/SUP], Mohammad Rizki Akbar[SUP] 3 [/SUP]
Affiliations
Abstract
Background: This systematic review and meta-analysis aimed to assess whether ventricular longitudinal strain can be used as a prognostication tool in patients with coronavirus disease 2019 (COVID-19).
Methods: Systematic literature searches of PubMed, Embase, and EuropePMC databases were performed on 16 November 2020. Left ventricular global longitudinal strain (LV-GLS) refers to LV contraction measurement using the speckle tracking-based method refers to the mean of strain values of the RV free wall (three segments) measured using echocardiography. The main outcome was poor outcome, defined as a composite of mortality and severe COVID-19.
Results: Seven studies comprising of 612 patients were included in meta-analysis. Six studies have mortality as their outcome, and 1 study has severity as their outcome. Patients with poor outcome have lower LV-GLS (SMD 1.15 (0.57, 1.72), p < 0.001; I[SUP]2[/SUP] 70.4%). Each 1% decrease in LV-GLS was associated with 1.4x increased risk of poor outcome (OR 1.37 (1.12, 1.67), p = 0.002; I[SUP]2[/SUP] 48.8%). Patients with poor outcome have lower RV-LS (SMD 1.18 (0.91, 1.45), p < 0.001; I[SUP]2[/SUP] 0%). Each 1% decrease in RV-LS was associated with 1.3x increased risk of poor outcome (OR 1.25 (1.15, 1.35), p < 0.001; I[SUP]2[/SUP] 11.8%). Subgroup analysis showed that for every 1% decrease in LV-GLS and RV-LS is increased mortality with OR of 1.30 (1.12, 1.50) and OR of 1.24 (1.14, 1.35), respectively.
Conclusion: This study shows that lower LV-GLS and RV-LS measurements were associated with poor outcome in patients with COVID-19.
Trial registration: PROSPERO CRD42020221144.
Keywords: COVID-19; Echocardiography; Longitudinal strain; SARS-CoV-2; Ventricle.
. 2021 Jan 12;9(1):9.
doi: 10.1186/s40560-020-00519-3.
Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis
Arief Wibowo[SUP] 1 [/SUP], Raymond Pranata[SUP] 1 2 [/SUP], Astri Astuti[SUP] 1 [/SUP], Badai Bhatara Tiksnadi[SUP] 1 [/SUP], Erwan Martanto[SUP] 1 [/SUP], Januar Wibawa Martha[SUP] 1 [/SUP], Augustine Purnomowati[SUP] 1 [/SUP], Mohammad Rizki Akbar[SUP] 3 [/SUP]
Affiliations
- PMID: 33436101
- PMCID: PMC7802997
- DOI: 10.1186/s40560-020-00519-3
Abstract
Background: This systematic review and meta-analysis aimed to assess whether ventricular longitudinal strain can be used as a prognostication tool in patients with coronavirus disease 2019 (COVID-19).
Methods: Systematic literature searches of PubMed, Embase, and EuropePMC databases were performed on 16 November 2020. Left ventricular global longitudinal strain (LV-GLS) refers to LV contraction measurement using the speckle tracking-based method refers to the mean of strain values of the RV free wall (three segments) measured using echocardiography. The main outcome was poor outcome, defined as a composite of mortality and severe COVID-19.
Results: Seven studies comprising of 612 patients were included in meta-analysis. Six studies have mortality as their outcome, and 1 study has severity as their outcome. Patients with poor outcome have lower LV-GLS (SMD 1.15 (0.57, 1.72), p < 0.001; I[SUP]2[/SUP] 70.4%). Each 1% decrease in LV-GLS was associated with 1.4x increased risk of poor outcome (OR 1.37 (1.12, 1.67), p = 0.002; I[SUP]2[/SUP] 48.8%). Patients with poor outcome have lower RV-LS (SMD 1.18 (0.91, 1.45), p < 0.001; I[SUP]2[/SUP] 0%). Each 1% decrease in RV-LS was associated with 1.3x increased risk of poor outcome (OR 1.25 (1.15, 1.35), p < 0.001; I[SUP]2[/SUP] 11.8%). Subgroup analysis showed that for every 1% decrease in LV-GLS and RV-LS is increased mortality with OR of 1.30 (1.12, 1.50) and OR of 1.24 (1.14, 1.35), respectively.
Conclusion: This study shows that lower LV-GLS and RV-LS measurements were associated with poor outcome in patients with COVID-19.
Trial registration: PROSPERO CRD42020221144.
Keywords: COVID-19; Echocardiography; Longitudinal strain; SARS-CoV-2; Ventricle.